Home » Topics » Disease categories and therapies » Immune

Immune
RSS

ZymoGenetics licenses to Novo Nordisk rights to IL-28A, IL-29 and IL-31

July 8, 2004

ID Biomedical's acquisition of Shire's vaccine business nears completion

July 5, 2004

Selective glucocorticoid receptor modulator may prevent progression of multiple sclerosis

July 2, 2004

Immunization completed in phase I ragweed allergy immunotherapy study

July 1, 2004

Two series of immunomodulating agents newly described by BMS scientists

July 1, 2004

Novel monoclonal antibody promising against graft rejection

June 30, 2004

Vertex scientists prepare and test new inhibitors of JAK, JNK, CDK, etc.

June 29, 2004

Preclinical studies on possible effects of anti-human Fas antibody R-125224 in autoimmune diseases

June 28, 2004

GPI-0100 to be studied by Memorial Sloan-Kettering under new agreement

June 25, 2004

DOR BioPharma and Jefferson enter CRADA for botulinum toxin vaccines

June 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.